{"id":"a73a050a-ee02-53b8-a953-cb0a4fcd63b5","stable_key":"10629adf-a816-5b7b-82db-a76bfbb946f2:bg-the-effect-is-not-ethnicity-specific","predicate":"reduces","statement":"LDL cholesterol after 4 weeks was influenced by baseline LDL cholesterol and treatment but not ethnicity with p = 0.74, in all subjects compared to control the three bioactive arms reduced LDL cholesterol significantly by 4.8 to 6.5% while the 4 gram low molecular weight arm had no effect, and the bioactive oat beta-glucan treatments reduced LDL cholesterol by a combined mean of 0.18 mmol/L or 4.8% in Caucasians, a value not significantly different from the 0.37 mmol/L or 10.3% reduction in non-Caucasians, with insufficient power to determine if the magnitude differed by ethnicity.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"85925a28-561e-59f7-8b22-828472f1814e","mechanism_event_label":"The effect showed up in both groups, and the trial was too small to say whether it is bigger in one.","subject":{"id":"fa30a72e-ed34-59eb-badd-236561a8db88","slug":"oat-beta-glucan","display_name":"Oat mixed-linkage beta-(1->3)/(1->4)-glucan","entity_type_key":"chemical_species"},"object":{"id":"ac5f5914-4824-5f9b-93c7-a6b5a52b53af","slug":"ldl-cholesterol-concentration","display_name":"LDL cholesterol concentration","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"85925a28-561e-59f7-8b22-828472f1814e","stable_key":"10629adf-a816-5b7b-82db-a76bfbb946f2:bg-the-effect-is-not-ethnicity-specific-event","event_type":"observed_intervention","label":"The effect showed up in both groups, and the trial was too small to say whether it is bigger in one.","description":"LDL cholesterol after 4 weeks was influenced by baseline LDL cholesterol and treatment but not ethnicity with p = 0.74, in all subjects compared to control the three bioactive arms reduced LDL cholesterol significantly by 4.8 to 6.5% while the 4 gram low molecular weight arm had no effect, and the bioactive oat beta-glucan treatments reduced LDL cholesterol by a combined mean of 0.18 mmol/L or 4.8% in Caucasians, a value not significantly different from the 0.37 mmol/L or 10.3% reduction in non-Caucasians, with insufficient power to determine if the magnitude differed by ethnicity.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"b74a821a-9a50-5bb3-955e-2177930567bc","slug":"glucan-molecular-weight","display_name":"Molecular weight of a glucan polymer","entity_type_key":"cellular_process"},"role":"effect_modifier","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"fca72f53-5c06-5fcb-8a0b-f48514e63762","slug":"glucan-depolymerisation","display_name":"Depolymerisation of a glucan polymer","entity_type_key":"cellular_process"},"role":"attenuating_process","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"fa30a72e-ed34-59eb-badd-236561a8db88","slug":"oat-beta-glucan","display_name":"Oat mixed-linkage beta-(1->3)/(1->4)-glucan","entity_type_key":"chemical_species"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"ac5f5914-4824-5f9b-93c7-a6b5a52b53af","slug":"ldl-cholesterol-concentration","display_name":"LDL cholesterol concentration","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/glucan-research/22118569.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"e1f7121d5a128b1e43ab60ba66394c7ca094617309c976e0b4c8c92ac46b4f23\", \"start_char\": 0, \"end_char\": 1812, \"text_sha256\": \"e1f7121d5a128b1e43ab60ba66394c7ca094617309c976e0b4c8c92ac46b4f23\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Post-hoc analysis of the same four-week multicentre trial by participant ethnicity","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"The same oat beta-glucan molecular weight and dose arms, analysed in Caucasian and non-Caucasian subgroups","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A post-hoc subgroup analysis of a trial designed to answer a different question, and the authors state it was underpowered to detect a difference between the groups.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair.","comparator":null,"unit":null,"notes":"","entity":{"slug":"beta-glucan","display_name":"Beta-glucan","entity_type_key":"chemical_species"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The effect showed up in both groups, and the trial was too small to say whether it is bigger in one.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[bg-p22118569] Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians. (2011). https://pubmed.ncbi.nlm.nih.gov/22118569/ DOI: 10.1186/1475-2891-10-130","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Serum LDL cholesterol","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"fb27ad91-96e4-5c8c-b289-7b29cf3d3c8a","evidence_kind":"source_excerpt","locator":"Lines 528-539","start_line":528,"end_line":539,"excerpt":"### bg-the-effect-is-not-ethnicity-specific\nLDL cholesterol after 4 weeks was influenced by baseline LDL cholesterol and treatment but not ethnicity with p = 0.74, in all subjects compared to control the three bioactive arms reduced LDL cholesterol significantly by 4.8 to 6.5% while the 4 gram low molecular weight arm had no effect, and the bioactive oat beta-glucan treatments reduced LDL cholesterol by a combined mean of 0.18 mmol/L or 4.8% in Caucasians, a value not significantly different from the 0.37 mmol/L or 10.3% reduction in non-Caucasians, with insufficient power to determine if the magnitude differed by ethnicity.\nCondition category: normal\nnutrient_topic: Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair.\nplain_language: The effect showed up in both groups, and the trial was too small to say whether it is bigger in one.\norganism: Human\ntissue_or_cell_type: Serum LDL cholesterol\nexperimental_model: Post-hoc analysis of the same four-week multicentre trial by participant ethnicity\nlimitations: A post-hoc subgroup analysis of a trial designed to answer a different question, and the authors state it was underpowered to detect a difference between the groups.\nexposure: The same oat beta-glucan molecular weight and dose arms, analysed in Caucasian and non-Caucasian subgroups\nevidence_span: {\"source_cache\": \"artifacts/glucan-research/22118569.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"e1f7121d5a128b1e43ab60ba66394c7ca094617309c976e0b4c8c92ac46b4f23\", \"start_char\": 0, \"end_char\": 1812, \"text_sha256\": \"e1f7121d5a128b1e43ab60ba66394c7ca094617309c976e0b4c8c92ac46b4f23\"}\n[bg-p22118569] Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians. (2011). https://pubmed.ncbi.nlm.nih.gov/22118569/ DOI: 10.1186/1475-2891-10-130","model_system":"Post-hoc analysis of the same four-week multicentre trial by participant ethnicity","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [bg-p22118569] Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians. (2011). https://pubmed.ncbi.nlm.nih.gov/22118569/ DOI: 10.1186/1475-2891-10-130","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"74dc223d-8289-57bf-a731-d220fa017c1e","stable_key":"import-10629adf-a816-5b7b-82db-a76bfbb946f2","title":"Beta-glucan: a structural family rather than an agent, what decides whether a bound glucan actually signals, the complement route that a cereal and a yeast preparation share, and the unequal human evidence behind each (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"7c62f2d2f8d99b650e6dc26a505b0f053ae1c8bdb38099d4dfc0771f65287461","revision_id":"a53bb794-0a4b-525d-9cf7-22b46a5403b0","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}